CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis [Phase 3]
Summary
A Phase III trial evaluated the efficacy of botulinum toxin for treating epicondylitis and has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Epicondylitis | Phase 3 | Status: COMPLETED